Member Info for Blockbuster1

Yep absolutely spot on! He’s currently up to an average of 3 posts per day over the last 30 days. Where his overall average is less than 1 post per day. His activity noticeably increases as the share price plummets. He’s either being paid to ramp this hand try and hold up the share price. Or he’s doing it to suit his own strategy. Either way beware, and take his posts with a very large pinch of salt!!

Given the extreme amount of ramping you’ve done, an awful lot of people will have a claim against you should this ho where it’s currently heading, down the toilet!

The situation is VERY concerning to say the least. At this rate of decline we could be in the low teens by the end of next week. GLALTH I think we need it!

Well it depends on your strategy and mine is not to swing trade. Also difficult to dispose of large volumes of this stock in a short time. I certainly am sat on a loss as I’ve accumulated over time. The market isn’t reacting to where we have got to. There is a reason behind that. The delays are concerning, the return of 737 is concerning, our ability to drive monetisation and move at anything other than a snails pace is also equally concerning.

So why do we sit at just 0,045p a share if what you say is true? Quite a simple question, surely if we are genuinely further on and in a better position than ever before our share price would reflect that. Yet we sit at 5% of that peak price you referred to a 2000% reduction in value. I for one am very very concerned.

As I sit and reflect on the current share price of just 0.045P pre consolidation, I do wonder how we move forward and why we languish at these low levels. This entry point was available 15 years ago when I first starting accumulating stock. So 15 years of effort and investment and we’ve moved nowhere. I do worry now for the commercialisation of this business. I wonder if this has been some lifestyle business and John and Tim ride off into retirement with zero value realised for shareholders who have funded that retirement. It will be interesting to see this play out, it’s definitely boom or bust and I’m getting less confident of the boom by the day. I suspect we will know where we stand inside the next 12 months. GLALTH

This is like listening to a broken record. Why do you keep regurgitating the same stuff time and time again? Please give it a rest, it’s incredibly boring now!

A very disappointing statement. I thought we might get thrown some bone in an attempt to move the share price forward. But absolutely nothing in this announcement that will help do that. You can only conclude that there are no advanced talks with industry parties. And the fact that Sareum is still putting itself in the shop window at events, would indicate this too.

I don’t see the position changing in the foreseeable future, until some good news of a licensing offer is announced. I suspect we’re six months plus away from that point, with the possibility of further fund raising at that time if we still have no interested parties on board.

I only take notice of people investing 7 figure sums, so your small change doesn’t count. Is it nice in your la la land?

Oh really, how did you support the 20p raise then, I’m intrigued to here this

I think is reasonable to assume early Q3 2025. Rodent studies will cost circa $2M and take six months. Larger animal studies cost double and take twice as long and I don’t see us having a funding runway for that.

I believe we’ll run the chronic toxicity studies and on a successful outcome then on license. This must be a route to a bigger up front license fee, or otherwise we’d be looking to license now…….

These studies are quite common prior to a drug entering phase 2. They typically last up to 6 months if conducted in rodents and 9-12 months if they are conducted on dogs or monkeys. I’d expect clarity on the method, and timeline, in the forward looking statement. I’m sorry if this is disappointing to those who believe there is some mysterious or spectacular reason for this pathway. This is simply business as usual.

“Headline data are as good as we could have wished for”

Above was Parker’s tweet of 1st July when the rns was released announcing the end of phase 1 trails.

They need to turn a best in class drug, with significant advantages over it’s competitors into cash for shareholders.

Will they be able to monetise this asset and get it licensed in a way to meaningfully affect the share price? We’ll hopefully soon find out.

Oh dear, how did you become so brainwashed? Only through balanced discussion will you make the right decision(s). Blindly following the herd based in you liking their current direction of travel will get you into all sorts of danger and risk that might not be palatable. As Boris found out the herd can change direction very quickly!

Is this the reason for the recent retrace? A potential up to 45 billion liability would mean much less funding available for M&A activities?

https://www.bloomberg.com/news/articles/2022-08-11/sanofi-and-gsk-lead-30-billion-rout-as-zantac-worries-mount

I tend to agree I think this may drift lower to circa £1.50. however, I'm a buyer at this level and slowly accumulating my position. Happy to buy at this price.

How soon we can forget! It is only a year ago Tim was telling all how cleaver his was and how he turned circa £20M investment into £250M + market cap . A year on and that market cap has halved for those that remained invested . I've only just started my investment journey but I've watched the video of the last investor meet sessions. Surely the one simple question is what is he doing to restore the shareholder value that has been lost in the last year that he so clearly claims he built and how quickly?

My gosh, is there no end to the rediculous ramping of this share. Right now £4 looks very attractive. £100 you need to take a sanity check ??

I suspect at a premium. Reading through the RNS trail trail the last placing were at a market rate with a kickback on meeting price targets. I've started to accumulate and will continue to do so around this price point. Little stock available though.

I can't imagine there will be much action over the next 6 - 8 weeks. Do you think there could be a wait until September now before further news flow,?